Klotho Neurosciences Inc/$GRML
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Klotho Neurosciences Inc
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Ticker
$GRML
Sector
Primary listing
Employees
5
Headquarters
Website
GRML Metrics
BasicAdvanced
$63m
-
-$0.22
2.43
-
Price and volume
Market cap
$63m
Beta
2.43
52-week high
$3.91
52-week low
$0.12
Average daily volume
3.1m
Financial strength
Current ratio
95.014
Quick ratio
93.489
Interest coverage (TTM)
-3.09%
Profitability
Management effectiveness
Return on assets (TTM)
-74.13%
Return on equity (TTM)
-198.18%
Valuation
Price to book
3.95
Price to tangible book (TTM)
5.22
Price to free cash flow (TTM)
-4.245
Free cash flow yield (TTM)
-23.56%
Free cash flow per share (TTM)
-0.121
Growth
Earnings per share change (TTM)
-31.90%
3-year earnings per share growth (CAGR)
624.59%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Klotho Neurosciences Inc stock?
Klotho Neurosciences Inc (GRML) has a market cap of $63M as of May 04, 2026.
What is the P/E ratio for Klotho Neurosciences Inc stock?
The price to earnings (P/E) ratio for Klotho Neurosciences Inc (GRML) stock is 0 as of May 04, 2026.
Does Klotho Neurosciences Inc stock pay dividends?
No, Klotho Neurosciences Inc (GRML) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Klotho Neurosciences Inc dividend payment date?
Klotho Neurosciences Inc (GRML) stock does not pay dividends to its shareholders.
What is the beta indicator for Klotho Neurosciences Inc?
Klotho Neurosciences Inc (GRML) has a beta rating of 2.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.